---
category: news
title: "Focus On - Licensing, Astellas"
excerpt: "US biotech Affinivax yesterday announced it has reacquired the exclusive worldwide rights to ASP3772, a novel vaccine candidate targeting Streptococcus pneumoniae, from Japanese pharma major Astellas Pharma."
publishedDateTime: 2022-04-09T17:15:00Z
originalUrl: "https://www.thepharmaletter.com/listing/focus-on/licensing-astellas?tagid[]=9&tagid[]=12711"
webUrl: "https://www.thepharmaletter.com/listing/focus-on/licensing-astellas?tagid[]=9&tagid[]=12711"
type: article
quality: 4
heat: 4
published: false

provider:
  name: The Pharma Letter
  domain: thepharmaletter.com

topics:
  - AI in Healthcare
  - AI

secured: "9i1WdDNLxOe19CN6cBd3HqlBTZ+zkbdlr5ihkaiTfYyx57XTgwkCF2+y+FXKzA6083TfkvSm/D/ZBezGXA5hzDxqOsLViVVifDB66Le83/PNGOSwTXpaerZ0M+cvZsMVmPXV4zvjWkq5eVXpghJpERfac6tsuRASwqkZ62jHTh+rIC4mXuXViWyqiz8hiiS2TnOCskp/Q4keBSKhAejHN1XW04X9dcMIw5b7TxUKvX258yicG40312LoiDAVaK7NTEGLLF0fZKEr3sH7JH2r7l4vrU+1QvyJsRqBzEfQ+bQjPU0+t9LqTBLs+IahCep78l+gTBDs+phTK6qPJLWQ7NuftKEIVt7rboIHT29oI+0=;m3TY825ofTDXjwn3Wohjig=="
---

